A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT02714608 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG: Ginsenoside H dripping pills
DRUG: Ginsenoside H dripping pills+Placebo
DRUG: Placebo

Sponsor

Tasly Pharmaceuticals, Inc.